While running a research site, Barry Lake became frustrated with the manual methods and inefficiencies of managing the trial pipeline and study startup workflows and inability of any existing software to go beyond traditional CTMS to enable the capture and analysis of performance metrics to differentiate one site from the next. Finding no solution, Lake founded Devana, a RealTime-eClinical Solutions company since mid-2023, whose “category-defining” Devana BI SaaS platform currently counts virtually every leading major site network as a valued client-partner. Devana helps site organizations who are growing and scaling, to automate their trial pipelines, automate and manage study startup workflows and, most importantly: capture, display for analysis and proactively report on site performance-metrics to “win more of the right trial awards”. Devana BI has now become “mission critical” software for the world’s leading site networks and SMOs. During COVID, Devana didn’t just talk about “DCT” or Decentralized Trials they went ahead and built the platform to support DCT: A secure cloud platform to host and scale decentralized trials that directly connected centralized clinical operations professionals with site-based clinicians for end-to-end collaboration during trial execution based on transparent site performance data. Devana’s upcoming game-changing innovation is TrialAlign set to be released at the SCRS Global Summit 2025. TrialAlign will leverage unbiased trial performance data to transform feasibility and site selection and directly connect and align the leading research sites, sponsors and CROs to reduce cycle time and greatly enhance clinical trial execution. By uniting all clinical trial stakeholders through performance and data transparency on a common cloud, Devana will fulfill its founding mission to help the clinical trials industry take a massive leap forward in what matters most: speeding therapeutic advances to patients.